Indication
Liver abscess
A liver abscess is a localized, pus-filled cavity within the hepatic parenchyma characterized by tissue destruction, liquefactive necrosis, and surrounding inflammation. Read more about Liver abscess
15 drugs 13 manufacturers
Drugs that treat it
Common Liver abscess therapies.
METRO IV (metronidazole in sodium chloride)
METRONIDAZOLE (metronidazole in sodium chloride)
METRONIDAZOLE (metronidazole in sodium chloride)
METRONIDAZOLE (metronidazole in sodium chloride)
METRONIDAZOLE (metronidazole in sodium chloride)
METRONIDAZOLE (metronidazole in sodium chloride)
METRONIDAZOLE (metronidazole in sodium chloride)
METRONIDAZOLE (metronidazole in sodium chloride)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA liver abscess is a localized, pus-filled cavity within the hepatic parenchyma characterized by tissue destruction, liquefactive necrosis, and surrounding inflammation.
It primarily affects the gastrointestinal and hepatobiliary systems and arises through ascending biliary infection, hematogenous seeding via the portal or systemic circulation, direct extension from adjacent abdominal structures, or penetrating trauma.
Etiologies are predominantly pyogenic—frequently polymicrobial with enteric pathogens such as *Escherichia coli* and *Klebsiella pneumoniae*—or amebic, caused by *Entamoeba histolytica*.
Clinically, affected patients characteristically present with systemic manifestations including fever, chills, leukocytosis, and right upper quadrant abdominal pain, which carry a significant risk of sepsis or rupture if left untreated.
- nih.gov
A liver abscess is a localized, pus-filled cavity within the hepatic parenchyma characterized by tissue destruction, liquefactive necrosis, and surrounding inflammation
- nih.gov
A liver abscess is a localized, pus-filled cavity within the hepatic parenchyma characterized by tissue destruction, liquefactive necrosis, and surrounding inflammation Etiologies are predominantly pyogenic—frequently polymicrobial with enteric pathogens such as *Escherichia coli* and *Klebsiella pneumoniae*—or amebic, caused by *Entamoeba histolytica* Clinically, affected patients characteristically present with systemic manifestations including fever, chills, leukocytosis, and right upper quad...
- nih.gov
It primarily affects the gastrointestinal and hepatobiliary systems and arises through ascending biliary infection, hematogenous seeding via the portal or systemic circulation, direct extension from adjacent abdominal structures, or penetrating trauma Etiologies are predominantly pyogenic—frequently polymicrobial with enteric pathogens such as *Escherichia coli* and *Klebsiella pneumoniae*—or amebic, caused by *Entamoeba histolytica* Clinically, affected patients characteristically present with ...
- ummhealth.org
It primarily affects the gastrointestinal and hepatobiliary systems and arises through ascending biliary infection, hematogenous seeding via the portal or systemic circulation, direct extension from adjacent abdominal structures, or penetrating trauma Clinically, affected patients characteristically present with systemic manifestations including fever, chills, leukocytosis, and right upper quadrant abdominal pain, which carry a significant risk of sepsis or rupture if left untreated
Personalize your experience
Follow Liver abscess and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.